Sidenius N - Search Results

1

Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice.

Sier CF, Nicoletti I, Santovito ML, Frandsen T, Aletti G, Ferrari A, Lissoni A, Giavazzi R, Blasi F, Sidenius N. Sier CF, et al. Among authors: sidenius n. Thromb Haemost. 2004 Feb;91(2):403-11. doi: 10.1160/TH03-06-0351. Thromb Haemost. 2004. PMID: 14961171

2

Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor.

Andolfo A, English WR, Resnati M, Murphy G, Blasi F, Sidenius N. Andolfo A, et al. Among authors: sidenius n. Thromb Haemost. 2002 Aug;88(2):298-306. Thromb Haemost. 2002. PMID: 12195704

3

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

Sidenius N, Blasi F. Sidenius N, et al. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22. doi: 10.1023/a:1023099415940. Cancer Metastasis Rev. 2003. PMID: 12784997 Review.

4

Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.

Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, Sidenius N. Cunningham O, et al. Among authors: sidenius n. EMBO J. 2003 Nov 17;22(22):5994-6003. doi: 10.1093/emboj/cdg588. EMBO J. 2003. PMID: 14609946 Free PMC article.

5

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.

Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. Cinque P, et al. Among authors: sidenius n. Ann Neurol. 2004 May;55(5):687-94. doi: 10.1002/ana.20076. Ann Neurol. 2004. PMID: 15122709

6

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.

Blasi F, Sidenius N. Blasi F, et al. Among authors: sidenius n. FEBS Lett. 2010 May 3;584(9):1923-30. doi: 10.1016/j.febslet.2009.12.039. Epub 2009 Dec 27. FEBS Lett. 2010. PMID: 20036661 Free article. Review.

7

Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance.

Sier CF, Sidenius N, Mariani A, Aletti G, Agape V, Ferrari A, Casetta G, Stephens RW, Brünner N, Blasi F. Sier CF, et al. Among authors: sidenius n. Lab Invest. 1999 Jun;79(6):717-22. Lab Invest. 1999. PMID: 10378514

8

Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin.

Sidenius N, Blasi F. Sidenius N, et al. FEBS Lett. 2000 Mar 17;470(1):40-6. doi: 10.1016/s0014-5793(00)01282-5. FEBS Lett. 2000. PMID: 10722842 Free article.

9

Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo.

Sidenius N, Sier CF, Blasi F. Sidenius N, et al. FEBS Lett. 2000 Jun 9;475(1):52-6. doi: 10.1016/s0014-5793(00)01624-0. FEBS Lett. 2000. PMID: 10854857 Free article.

10

Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.

Sidenius N, Andolfo A, Fesce R, Blasi F. Sidenius N, et al. J Biol Chem. 2002 Aug 2;277(31):27982-90. doi: 10.1074/jbc.M111736200. Epub 2002 May 28. J Biol Chem. 2002. PMID: 12034711 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters